Treatment and diagnostics testicular cancer in Tokyo, Japan

Testicular cancer is a oncological neoplasm of testicular tissue that can occur in a man of any age. The tumor is not aggressive, but it requires early therapy — and that is what effectively guarantees recovery and survival. Treatment of testicular cancer in Tokyo is carried out by competent specialists with extensive clinical experience. They use advanced diagnostic and therapeutic capabilities, ensuring favorable outcomes even in advanced cases.

Diagnosis in Tokyo is performed by the following methods:

• laboratory studies (tests for CEA, alpha-fetoprotein, beta-hCG, and other markers),
• ultrasound of the scrotum,
• MRI and MR angiography of the external genital organs,
• PET-CT and CT of the abdominal cavity and pelvis,
• ultrasound of sentinel lymph nodes,
• lymph node puncture,
• biopsy of testicular tissue with pathological, morphological, and cytological assessment.

The therapeutic program is prepared individually, taking into account the patient’s age, general health, concomitant or provoking conditions, the stage of cancer, and other parameters.

The following procedures are used in treatment:

• systemic polychemotherapy or monochemotherapy,
• hyperthermic intraperitoneal chemotherapy,
• contact radiotherapy,
• radiation therapy on a linear accelerator,
• bio-, immune-, and hormone therapy,
• unilateral or bilateral robot-assisted orchiectomy,
• orchiectomy with retroperitoneal lymph node dissection.

If the treatment plan includes radical surgery, the patient is counseled by clinical geneticists and reproductive specialists. Patients who have undergone prolonged antitumor therapy are offered a rehabilitation program in the city’s hospitals.